HOME >> MEDICINE >> NEWS
Acrux reports progress in development of Testosterone MD-Lotion(R) for men

Acrux Limited (ASX: ACR), the Australian pharmaceutical company which specialises in administering drugs through the skin, today announced positive results from two more clinical studies of its Testosterone MD-Lotion treatment for testosterone deficiency in men, which is associated with a number of symptoms including lethargy, depression and reduced libido. Both studies were conducted at the Centre for Clinical Studies, Melbourne, with Professor Susan Davis supervising as Principal Investigator.

The studies compared blood levels of testosterone in healthy volunteers. The aim of the first study was to compare two different formulations of Testosterone MD Lotion, and the aim of the second study was to compare two different application sites.

The results of the first study showed that both formulations provided similar blood levels, providing options for continued development of either formulation. In the second study, there was a significant difference in absorption between the two different application sites, providing important information for the design of the remaining clinical studies in men.

In both studies, the lotion was well tolerated, with no application site reactions noted, and no serious adverse events recorded. Full details of the studies are presented in Appendix 1.

Acrux's development of Testosterone MD Lotion is continuing, with further studies to commence shortly to confirm the doses required to maintain testosterone blood levels in the target range for effective treatment.

Acrux CEO and Managing Director, Dr Igor Gonda said: "We believe our fast drying, no-touch metered dose lotion has significant competitive advantage over the existing products in this growing market. The remaining trials suit our expertise and require moderate investment, so in line with our financial plans we intend to complete them ourselves before choosing the best option for sales and marketing".

The remaining development prog
'"/>

Contact: Igor Gonda
61-383-790-100
Research Australia
7-Sep-2005


Page: 1 2

Related medicine news :

1. Acrux completes enrollment in key phase 2 trial
2. Acrux and Oreganon further expand their collaboration
3. Acrux granted first grant in Europe, triggering payment from Lilly
4. Acrux patent portfolio advances in USA
5. Acrux acquires rights to commercialise worlds first contraceptive spray
6. Four new us patents granted to Acrux for transdermal drug delivery
7. New study reports hotel guests at risk from carbon monoxide poisoning
8. MIT reports key pathway in synaptic plasticity
9. ENDEAVOR III Trial reports key findings on new-generation stent
10. New study reports improved treatment and reduced mortality for patients with heart failure
11. Study reports changing to a low-fat diet can induce stress

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... (PRWEB) , ... January 15, 2019 , ... ... The Center for Inflammatory Bowel and Colorectal Diseases, Institute for Digestive Health ... invasive, outpatient procedure for treating hemorrhoids., A specially designed instrument known as a ...
(Date:1/14/2019)... ... January 14, 2019 , ... Specialty Technical Publishers (STP) ... Audit Protocol Consortium (IAPC) EHS audit protocol for Great Britain . Leading ... of their EHS regulatory obligations and rapidly collect, share, archive, and export audit ...
(Date:1/11/2019)... ... ... In Partnership with the Smiles for Everyone Foundation , Monarch Dental ... TX office on February 9. , Dental services provided include same-day procedures such ... For more information, please visit the Monarch Dental website . , About Monarch ...
(Date:1/10/2019)... ... 10, 2019 , ... Mount Sinai Health System is hosting ... United Nations Staff Recreation Council in support of the Helen Sawaya Fund, a ... music, art, massage, and pet therapies to increase the comfort and emotional and ...
(Date:1/10/2019)... DIEGO (PRWEB) , ... January 10, 2019 , ... ... education on CBD and Hemp companies, partners with NeuCana Companion to educate dog ... owners. , CBD is believed to help calm pain and anxiety related ailments ...
Breaking Medicine News(10 mins):
(Date:1/11/2019)... HOUSTON (PRWEB) , ... January 11, 2019 , ... According ... thanks to Top Acupuncture , people are now able to receive the respiratory ... or diseases. We focus on the root causes of imbalance as well. Acupuncture and ...
(Date:1/11/2019)... (PRWEB) , ... January 11, 2019 , ... ... products and solutions, is now helping customers transform their gut health. The global ... probiotics and digestive enzymes that complement each other to support better daily digestion ...
(Date:1/10/2019)... ... January 10, 2019 , ... ... new A-Series Advantage Anesthesia Delivery platform, providing a modular, state-of-the-art family of anesthesia ... enabling Mindray to continue its unwavering commitment to perioperative care. , “The ...
Breaking Medicine Technology:
Cached News: